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ABSTRACT
Human blood is often used as an ex vivomodel to mimic the environment encountered
by pathogens inside the host. A significant variety of experimental conditions has been
reported. However, optimization strategies are often not described. This study aimed to
evaluate key parameters that are expected to influence Staphylococcus epidermidis gene
expression when using human blood ex vivo models. Our data confirmed that blood
antimicrobial activity was dependent on initial bacterial concentration. Furthermore,
blood degradation over time resulted in lower antimicrobial activity, with a 2% loss
of leukocytes viability correlating with a 5-fold loss of antimicrobial activity against
S. epidermidis. We further demonstrated that the volume of human blood could be
reduced to as little as 0.18 mL without affecting the stability of gene expression of the
tested genes. Overall, the data described herein highlight experimental parameters that
should be considered when using a human blood ex vivo model for S. epidermidis gene
expression analysis.
Subjects Microbiology, Molecular Biology, Infectious Diseases
Keywords Bacterial survival, Staphylococcus epidermidis, Human blood ex vivo model, Volume of
human blood, Gene expression
INTRODUCTION
Staphylococcus epidermidis is a commensal inhabitant of healthy human skin and mucosae
that can cause important infections, such as medical device-associated bloodstream
infections (Otto, 2009). Due to the clinical relevance of these infections, it is important to
understand the strategies employed by S. epidermidis to evade the host immune system
response. In order to better comprehend how S. epidermidis adapts to the host, gene
expression studies are often conducted under conditions that try to mimic the in vivo
environment (Loza-Correa et al., 2019). Human blood ex vivo models have contributed
to a better understanding of how pathogens survive in human blood, by evaluating the
transcriptional response during incubation in human blood, as well as, by exploring
host-pathogen interactions. These models are relatively easy to implement, have been
reported in many clinically relevant microorganisms, including S. epidermidis (França
et al., 2014; Qin et al., 2017), Staphylococcus aureus (Malachowa et al., 2011), Neisseria
meningitidis (Echenique-Rivera et al., 2011; Nolte et al., 2002) Streptococcus agalactiae
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(Mereghetti et al., 2008), Enterococcus faecalis (Vebo et al., 2009) and Candida albicans
(Fradin et al., 2005; Fradin et al., 2003; Hunniger et al., 2014).
However, the implementation of these models lacks often do not describe optimization
steps and, not surprisingly, a significant variety of experimental set-up conditions have
been reported (Fradin et al., 2003; França et al., 2014;Hedman et al., 2012;Qin et al., 2017).
Because different experimental designs can greatly influence experimental outcomes, we
became interested in evaluating key parameters that can compromise S. epidermidis gene
expression studies when using a human blood ex vivo model. To achieve this goal, we
evaluated the initial bacterial concentration and the volume of human blood in the
co-incubation assays, as well as leukocyte viability after blood collection, and assessed
bacterial survivability and gene expression under a human ex vivo blood model.
MATERIAL AND METHODS
Bacterial strains and growth conditions
S. epidermidis PT12003, isolated from a patient with a central catheter after stomach surgery
(Freitas et al., 2018), was used in this study. One single colony was inoculated into two mL
of Tryptic Soy Broth (TSB) (Liofilchem, Teramo, Italy) and incubated overnight at 37 ◦C
and at 120 rpm (ES-20 Shaker-Incubator, Biosan, Riga, Latvia). Planktonic cultures were
started by adjusting the optical density at 640 nm (OD640 nm), to 0.050 (±0.005) in 10
mL of TSB and grown, in a 25 mL flask, for 6 h at 37 ◦C and at 120 rpm. The suspension
was then washed once and resuspended in 0.9% NaCl. Before further experiments, the
OD640 nm of bacterial suspension was adjusted to 2.7 in order to obtain 1×109 CFU/mL.
Human blood collection
Peripheral blood was collected by venipuncture from Portuguese healthy adult volunteers
with an age range between 25–40 (7 female and 4 male donors), not taking antibiotics or
anti-inflammatory medication within the previous 14 days. Blood was drawn using one of
the following anticoagulant tubes: K3EDTA (Vacuette, Greiner Bio-one, Kremsmünster,
Austria), sodium citrate (Vacuette, Greiner Bio-one, Kremsmünster, Austria) or lithium
heparin (Becton Dickinson, NJ, USA). Blood was collected under a protocol approved by
the Institutional Review Board of the University of Minho (SECVS 002/2014 (ADENDA)),
which is in strict accordance with the Declaration of Helsinki and Oviedo Convention. All
donors gave written informed consent to have blood taken.
The influence of anticoagulants on bacterial growth
In order to explore the effect of different anticoagulants on bacterial growth, TSB
(Liofilchem, Teramo, Italy) was added to the different blood collection tubes and was
gently inverted 5 to 8 times, before being transferred to a 25 mL flask. Planktonic bacteria
obtained as described above was inoculated into TSB with the different anticoagulants,
at a final concentration of 107 CFU/mL. A negative control was included by inoculating
bacteria in TSB without anticoagulants. Bacterial suspensions were incubated for 24 h at
37 ◦C and at 120 rpm (ES-20 Shaker-Incubator). Bacterial growth was determined by CFU
quantification by taking aliquots every 2 h. The aliquots were serially diluted and plated
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on TSB agar using the (Miles, Misra & Irwin, 1938) and incubated at 37 ◦C. At least two
independent experiments with two technical replicates were performed.
The ability of bacteria to survive in human blood
For the evaluation of the ability of bacteria to survive in human blood, 0.1 mL of different
concentrations of exponentially growing bacteria, were added to 0.9 mL of human blood
in two mL tubes, to obtain final concentrations of 108, 107, 106, 105 or 104 CFU/mL and
incubated at 37 ◦C, at 80 rpm, for up to 8 h. Four and 8 h after incubation, the enumeration
of bacteria was determined by CFU counting, as described above. The number of CFU/mL
immediately (i.e., less than 2 min) after incubation with blood was used as a control to
calculate the percentage of survival. This experiment was performed five independent
times, using blood from five different donors.
Viability of human blood leukocytes over time
Human blood leukocytes viability after collection was used as an indicator of blood
degradation over time. Whole blood was collected and incubated for up to 8 h at 37 ◦C and
80 rpm (PSU-10i, Biosan). At time points 0 (immediately after collection), 4 h and 8 h,
two mL of whole blood was collected and incubated with five mL of red blood cells (RBC)
lysis buffer (Alfa Aesar, Karlsruhe, Germany). The suspension was mixed by carefully
inverting the tubes and then incubated at room temperature for 10 min. The reaction
was stopped by adding 15 mL of phosphate buffered saline (PBS) (Gibco, MA, USA).
Leukocytes were harvested by 10 min centrifugation at 300 g and 4 ◦C, and a new RBC
lysis cycle was performed to lyse residual red blood cells. Leukocytes were then suspended
in 0.5 mL of PBS and cells viability determined through flow cytometry (EC800, Sony
Biotechnologies Inc, CA, USA), using propidium iodide staining (5µg /mL, Sigma, MO,
USA). This experiment was performed three independent times, using blood from different
donors. Representative flow cytometry plots are presented in Fig. S1.
The impact of time after blood collection on bacterial survival in
human blood
Whole blood was collected and an aliquot (0.9 mL) was immediately taken and mixed
in a two mL tube with 0.1 mL of S. epidermidis, to obtain a final bacterial concentration
of 105 CFU/mL, and incubated at 37 ◦C and 80 rpm for 4 h. The remaining blood was
kept under the same temperature and agitation conditions for 4 h. After this time, a new
0.9 mL aliquot of blood was taken and a second incubation with 0.1 mL of S. epidermidis
was performed for another 4 h, in a new two mL tube. Bacteria was quantified by CFU
counting, as described above. This experiment was performed three independent times,
using blood from three different donors.
S. epidermidis gene expression assays
Three unrelated genes were selected as probes for assessing gene expression stability:
SERP_RS11970, SERP_RS10985 and SERP_RS08870. Two different experimental
conditions were tested: (i) the utilization of different anticoagulants on the collection
tubes and (ii) the reduction of the volume of blood used during the co-incubation assays
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Table 1 List of primers used for the quantification of gene expression by qPCR.




















(total incubation volume of one mL, 0.6 mL, 0.5 mL, and 0.2 mL). Blood samples were
transferred into two mL tubes and, then, bacteria were added to each tube to obtain a
final concentration of 108 CFU/mL. The tubes were incubated for 2 h at 37 ◦C and 80 rpm
(PSU-10i). After the co-incubation period, samples were sonicated for 5s at 33% amplitude
(Cole-Parmer 750- Watt Ultrasonic Homogenizer 230 VAC, IL, USA) to lyse eukaryotic
cells. Total RNA isolation, complementary DNA synthesis (cDNA) and quantitative
PCR (qPCR) were performed as previously optimized (França et al., 2012), with minor
modifications. In brief, after mechanical and chemical lysis of bacterial cells, total RNA
was purified using EZNA total RNA kit (Omega Biotek, GA, USA). Genomic DNA was
degraded by DNase I (Thermo Scientific, MA, USA) and cDNA synthesized, from 200 ng
of total RNA, by RevertAid M-MuLV reverse transcriptase (Thermo Fisher Scientific) and
using random primers (NZYTech, Lisboa, Portugal) as priming strategy. Finally, qPCR was
prepared bymixing 2µL of 1:100 diluted cDNAwith 5µL of Xpert Fast SYBR (Grisp, Porto,
Portugal), 0.5 µL of each forward and reverse primers at 0.5 µM and 2 µL of nuclease-free
water. The run was completed in a CFX96TM thermal cycler (Bio-Rad, CA, USA) with the
following cycling parameters: 3 min at 95 ◦C followed by 40 cycles of 5 s at 95 ◦C and 25 s at
60 ◦C. The primers used were designed using Primer3 software (Koressaar & Remm, 2007;
Untergasser et al., 2012) and synthesized at Metabion (Steinkirchen, Germany). Primers
sequences, size of the amplicon and reaction efficiency are presented in Table 1. The
quantification of the transcripts for each gene under study was determined using 16S
rRNA as reference gene and by applying the delta Cq method (E1Cq), a variation of the
Livak method (Livak & Schmittgen, 2001), where 1Cq = Cq (reference gene) −Cq (target
gene) and E is the experimentally determined reaction efficiency. Reaction efficiencies were
determined using the dilution method (Pfaffl, 2004) at 60 ◦C.
Statistical analysis
Statistical analysis was carried out with GraphPad Prism Version 6 Trial (CA, USA).
For comparisons among different groups one-way or two-away ANOVA, with Tukey’s
comparisons test, were used when appropriate (the tests used are detailed in the figure
caption). P < 0.05 was considered significant.
Brás et al. (2020), PeerJ, DOI 10.7717/peerj.9295 4/13
RESULTS AND DISCUSSION
Human blood ex vivo models have been developed to mimic bloodstream infections as
an affordable alternative to in vivo models (Echenique-Rivera et al., 2011; Malachowa et
al., 2011; Qin et al., 2017). During human blood collection, anticoagulants need to be
used to prevent blood clotting. It has been pointed out that different anticoagulants may
influence the experimental outcome (Freitas et al., 2008; Strobel & Johswich, 2018). The
most commonly used anticoagulants are heparin, citrate and EDTA (Engstad, Gutteberg &
Osterud, 1997). Citrate andEDTAprevent blood fromclotting through binding free calcium
ions (Strobel & Johswich, 2018), while heparin inhibits coagulation by enhancing the activity
of antithrombin III (Engstad, Gutteberg & Osterud, 1997). Herein, pilot experiments were
initially performed to determine the best anticoagulant for S. epidermidis gene expression
analysis. Thus, the influence of heparin, citrate, and EDTA was evaluated on bacterial
growth and transcription levels of the selected genes. As shown in Fig. S2, EDTA, but not
the other tested anticoagulants, inhibited bacterial growth in the first 8 h, eventually leading
to bacterial death, after 24 h of incubation. A similar effect was reported before in some
strains ofN. meningitidis, when using citrate as anticoagulant (Strobel & Johswich, 2018) but
in our experimental setup, we did not observed any inhibitory effect regarding S. epidermidis
growth. Interestingly, when analyzing bacterial gene expression no significant differences
were found among the different anticoagulants tested. Taken into consideration (i) these
pilot results, (ii) the availability and (iii) price difference between the anticoagulants tested,
and previous experimental results (França et al., 2014; Franca et al., 2016) we selected
heparin for the remaining the experiments.
An important issue related to human blood ex vivo models is the bacterial concentration
used. Although the quantity of microbes present in human blood during bacteremia is
estimated to be up to 104 CFU/mL (Opota et al., 2015), often higher concentrations of
bacteria have been used in human blood ex vivo models (Askarian et al., 2017; França et al.,
2014; Qin et al., 2017), mainly due to the lack of sensitivity of many experimental methods
to assess lower bacterial concentrations (Bacconi et al., 2014; Machado et al., 2013). For
instance, it is known that for the analysis of the transcriptomic response of bacteria, the
initial bacterial concentration needs to be significantly higher, to ensure a sufficient amount
of RNA for downstream applications (Hedman et al., 2012). To investigate the effect of
different initial bacterial concentration on the ability of S. epidermidis to survive in human
blood, different bacterial concentrations (104 to 108 CFU/mL) were used for the bacterial
survival assays. After 4 h and 8 h of co-incubation, the percentage of bacterial survival was
determined (Fig. 1). Since it is known that there is a significant source of experimental
variability when working with human samples, due to the inherent traits of the donors
such as age (Eady et al., 2005), gender (Whitney et al., 2003) and the proportion of different
blood cell populations (Cobb et al., 2005), this experiment was performed with blood from
five different donors, to increase the significance of our results. Not surprisingly, the ability
of S. epidermidis to survive in human blood was cell concentration dependent: the lower
the inoculum, the higher the percentage of bacterial killing by human blood (Fig. 1).
Interestingly, after 4 h of co-incubation, cell death was observed in all tested bacterial
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Figure 1 The effect of initial bacterial concentrations on the ability of S. epidermidis to survive in hu-
man blood after 4 h and 8 h of incubation. The bars represent the mean plus standard deviation of five
independent experiments, performed with five different donors. Statistical analysis was performed us-
ing two-way ANOVA and Tukey’s multiple comparisons test. Significant differences between 108 and the
other bacterial concentrations are depicted with ∗∗p< 0.01; ∗∗∗p< 0.001; ∗∗∗∗p< 0.0001.
Full-size DOI: 10.7717/peerj.9295/fig-1
concentrations but after 8 h of co-incubation, the higher concentration inocula presented
higher cell density than at time zero. This suggests that over time, and when the bacterial
inoculum was 108 CFU/mL, blood lost some antimicrobial activity leading to bacteria
growth.
To confirm that longer blood incubation periods would result in lower antimicrobial
activity, a second experiment was performed. For this assay, we selected a bacterial
concentration of 105 CFU/mL, taken in consideration the significant killing observed after
4 h of incubation (Fig. 1). As shown in Fig. 2A, the co-incubation of S. epidermidis with
human blood after 4 h, resulted in different bacterial killing rates, depending if the blood
was used immediately or 4 h after collection: while 97% of bacterial was killed if blood was
used immediately, only 84% of death was observed if we used blood 4 h after collection. It
is well described that blood antimicrobial activity against S. epidermidis involves important
components such as complement and leukocytes (Le, Park & Otto, 2018). As such, to
evaluate blood degradation, we assessed leukocytes viability right after blood collection,
and also 4 and 8 h after collection. As shown in Fig. 2B, right after blood collection, 3%
of leukocytes were already dead. This fact may be related to the process of collection and
processing time of human blood (Ferrante & Thong, 1980). The results also showed that
4 h after blood collection, cell death rate was slightly increased to 5% and then to 15% after
8 h. Interestingly, a 2% reduction in leukocyte viability (from 3 to 5%) was correlated with
13% reduction in antimicrobial activity (from 97% to 84%). However, it should be noted
that blood degradation over time will likely affect other important components that were
not quantified herein, such as complement (Nordahl et al., 2004). As such, based on these
results, it’s not possible to determine which exactmechanism involved in blood degradation
contributed to the effective loss of antimicrobial activity over time. Nevertheless, our data
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Figure 2 The influence of time after blood collection on bacterial survivability and leukocyte viabil-
ity. (A) Bacterial survivability after 4 h of co-incubation with blood. Bacteria was added to blood imme-
diately after collection or 4 h post-blood collection. Bacterial survivability was determined by CFU count-
ing. The bars represent the mean plus standard deviation of three independent experiments, performed
using three different donors. (B) Viability of human blood leukocytes after collection. Leukocytes viabil-
ity was assessed by flow cytometry immediately, 4 and 8 h after blood collection, before utilization in the
co-incubation assays. The bars represent the mean plus standard deviation of three independent experi-
ments, performed using three different donors. Statistical analysis was performed using one-way ANOVA
and Tukey’s multiple comparison test. ∗p< 0.05. ∗∗p< 0.01.
Full-size DOI: 10.7717/peerj.9295/fig-2
clearly confirms that longer waiting times after blood collection will contribute to blood
degradation. This fact is important to consider when planning ex vivo experiments with
blood, as it may have substantial consequences on the results obtained, especially if a
higher bacterial inoculum is needed, such as when performing RNA-sequencing (França
et al., 2014; Franca et al., 2016; Malachowa et al., 2011; Qin et al., 2017). Some studies have
used human blood ex vivo model with incubation periods up to 24 h (Nolte et al., 2002).
However, as shown by our results, 24 h is an extensive period of incubation which may
yield higher blood degradation and, as such, should be avoided when determining bacterial
survival studies in human blood. Blood degradation can occur when research laboratories
are not physically close to human blood collecting centers, and this should also be taken
into consideration when planning experiments using human blood. A simple way to reduce
this obstacle is to maintain the blood using gentle agitation (Afonso et al., 2010).
Another important practical aspect when considering using human blood as an ex-vivo
model is the limitation of blood availability. As such, the ability to reduce the volume of
blood per experiment, without compromising the results, is of interest. When analyzing
several published gene expression studies, it was observed that different volumes of human
blood, ranging from 0.2 mL to 80 mL per experiment, have been reported (Echenique-
Rivera et al., 2011; Hedman et al., 2012; Hunniger et al., 2014; Mereghetti et al., 2008; Qin et
al., 2017). As the long-term goal of our research group is to assess global transcriptomic
changes occurring with S. epidermidis gene expression, using ex vivo blood models, there
was interest in determining if reducing the volume of blood in the co-incubation assays
down to 0.18 mL had a detrimental effect on the stability of gene transcription. The starting
volume was 0.9 mL, in order to compare with our previous data obtained using RNA-seq
(França et al., 2014). For this assay, we selected a bacterial concentration of 108 CFU/mL to
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Figure 3 The influence of using different volumes of human blood in co-incubations assays on the sta-
bility of transcription levels of SERP_RS11970, SERP_RS10985 and SERP_RS08870 genes. Bacteria was
added to each tube to obtain a final concentration of 108 CFU/mL and then the tubes were incubated for
2 h at 37 ◦C. The bars represent the mean plus standard deviation of normalized expression of three inde-
pendent experiments, performed with three different donors. Statistical analysis was performed, respec-
tively, using one-way ANOVA and Tukey’s multiple comparisons test.
Full-size DOI: 10.7717/peerj.9295/fig-3
ensure a sufficient amount RNA that would be needed for future RNA-sequencing studies
(Hedman et al., 2012). The transcription of three unrelated genes was assessed. One of the
selected genes was sepA (SERP_RS08870), which codifies a protease that plays an important
role in bacterial immune invasion through the degradation of antimicrobial peptides
produced by the host (Lai et al., 2007). The two other selected genes were SERP_RS11970,
a gene that codifies a major facilitator superfamily and SERP_RS10985, a universal stress
protein. As shown in Fig. 3, no significant differences were found in the expression of the
selected genes using, in any of the different volumes of human blood tested. Noteworthy,
a volume of blood as low as 0.18 ml per reaction could be used without impacting the
transcription of the selected genes. Nevertheless, we acknowledge that a limitation of this
study was the fact that the selected genes had relative expressions (to the 16S ribosomal
RNA) between ∼10E−3 and ∼10E−7. While this is a very large dynamic range, we can’t
exclude the possibility that very low expressing genes (≤10E−8) could potentially be
affected differently.
CONCLUSION
There remains a great deal of work to be done in clarifying the factors that contribute to
S. epidermidis survival and adaptation to blood, which contribute to the evasion from the
host immune system. The improvement of human blood ex vivo models will contribute
to standardization of experimental conditions and produce a more reliable experimental
setup and, consequently, contribute to obtain results with higher clinical relevance. The
findings from the study are of technical importance for future studies since it highlights
key parameters that should be considered when using human blood as an ex vivo model for
the analysis of the gene expression of S. epidermidis, in particular, the possibility of using
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low volume of blood per reaction, without compromising the experimental results, at least
in regard to the parameters tested herein.
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